J3403 Revakinagene taroretcel-lwey, per implant
Short descriptor: Revakinagene, per implant
Look up J3403 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
J3403 is the HCPCS Level II code for Revakinagene taroretcel-lwey, per implant (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Medicare Coverage
- Carrier judgment (code C)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 2025-10-01
- 2026 Maintenance
- No change this year
Drug Details
- Drug / Substance
- Revakinagene taroretcel-lwey, per implant
See the full HCPCS Table of Drugs (J-codes).
References
Cite This Page
Reference J3403 with the canonical source and edition:
J3403 — Revakinagene taroretcel-lwey, per implant. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J3403
Canonical URL: https://icd10codingpro.com/hcpcs-codes/J3403